Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Rauth

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Biology|January 3, 2013
Notes from the editorsRichard Hill, Mike Rauth, Dianne Dixon
Journal of Pharmaceutical Sciences|July 6, 2004
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizersHo Lun Wong, Reina Bendayan, Andrew Mike Rauth, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2006
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancerHo Lun Wong, Reina Bendayan, Andrew Mike Rauth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 13, 2006
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor modelHo Lun Wong, Andrew Mike Rauth, Reina Bendayan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Biology|January 3, 2013
Notes from the editorsRichard Hill, Mike Rauth, Dianne Dixon
Journal of Pharmaceutical Sciences|July 6, 2004
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizersHo Lun Wong, Reina Bendayan, Andrew Mike Rauth, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 14, 2006
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancerHo Lun Wong, Reina Bendayan, Andrew Mike Rauth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 13, 2006
In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor modelHo Lun Wong, Andrew Mike Rauth, Reina Bendayan, et al.
Pageof 1